Abstract
Depression is a common psychiatric disorder. Although a variety of antidepressant medications have been shown to be effective, psychological therapies are highly valued by patients and some (such as cognitive-behavioral therapy) may be as clinically effective as antidepressants. Given similar clinical effectiveness, issues of differences in costs between cognitive-behavioral therapy, medication treatments and other approaches to mental healthcare are important The current article discusses issues relating to the evaluation of the cost-effectiveness of cognitive-behavioral therapy for depression, reviews current empirical evidence concerning cost-effectiveness and highlights key issues for future research.
| Original language | English |
|---|---|
| Pages (from-to) | 457-465 |
| Number of pages | 8 |
| Journal | Expert Review of Pharmacoeconomics and Outcomes Research |
| Volume | 2 |
| Issue number | 5 |
| DOIs | |
| Publication status | Published - Oct 2002 |
Keywords
- Cognitive-behavioral therapy
- Cost-effectiveness
- Depression
- Economic evaluation